James Park has served as a member of our board of directors since January 2023 and has served as President and Chief Executive Officer of GC Cell Corporation (GC Cell), a South Korean public biotechnology company, since January 2023, as well as a member of their board of directors since March 2023. Mr. Park also has served as Interim Chief Executive Officer of BioCentriq, a private contract development and manufacturing organization, since June 2023. Previously, Mr. Park held various roles at Samsung Biologics, including serving as Executive Vice President, Chief Business Officer, from January 2022 to January 2023, Senior Vice President, Chief Business Officer, from March 2018 to December 2021, and Vice President, Global Business Development from November 2015 to February 2018. Prior to joining Samsung Biologics in 2015, Mr. Park was Director, Strategy & Alliance Integration for Bristol-Myers Squibb. Mr. Park received his B.S. in Chemical Engineering from the University of California, Davis, and his M.S. in Industrial Engineering & Operations Research from Columbia University. Our board of directors believes that Mr. Park’s extensive business and executive-level management experience in the biotechnology industry qualifies him to serve on our board of directors.